|
P.A. Krainii, K. S. Ibishev
Electronic microscopy assessment of immunological disorders in the secret of the prostate in patients with chronic recurrent bacterial prostatitis
|
№4 / 2021
|
|
A.Y. Tsukanov, N.V. Rudchenko, S.I. Mozgovoy, A.V. Maslyukov
Protection of the prostate in conditions
of chronic pelvis varicose
|
№4 / 2021
|
|
A.V. Kuzmenko, Yu.Yu. Vinnik, V.V. Kuzmenko, T.A. Gyaurgiev
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
|
№3 / 2021
|
|
E.V. Kulchavenya, E.V. Brijatuk, D.P. Kholtobin, A.G. Cherednichenko
Current approach to diagnosis of chronic prostatitis
|
№2 / 2021
|
|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev
Entomological drug adenosine for the treatment of patients with benign prostatic hyperplasia and chronic prostatitis
|
№1 / 2021
|
|
E.V. Kulchavenya, S.Yu. Shevchenko, A.G. Cherednichenko, A.A. Breusov, A.A. Vinitskiy
New opportunities of using gialuronidase in chronic prostatitis
|
№3 / 2020
|
|
M.I. Davidov
Sexual dysfunction in patients with chronic prostatitis and its treatment
|
№1 / 2020
|
|
E.V. Dariy, K.A. Tirsy, N.A. Grigoriev
Efficiency assessment of low intensity-shokwave therapy in the treatment of chronic pelvic pain syndrome
|
№1 / 2020
|
|
M.I. Katibov, M.M. Alibekov
Transrectal ozone and magnetic therapy for treatment of chronic bacterial prostatitis
|
№6 / 2019
|
|
D.V. Ergakov, A.G. Martov, D.E. Turin
Use of cytomedins in case of prostatic involvement in chronic prostatitis according to UPOINT classification
|
№3 / 2019
|
|
A.B. Zhiborev, A.G. Martov
The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia
|
№4 / 2018
|
|
E.V. Kulchavenya, O.P. Shvetsova, A.A. Breusov
Rationale of use and effectiveness of Longidaza in patients with chronic prostatitis
|
№4 / 2018
|
Русский
